People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
Category: Clinical Trials
-
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.
-
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.
A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.
-
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
-
New Gene Therapy Enables Children With a Rare Form of Deafness to Hear
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.
-
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
-
A Cancer Detection Test Fails in Major Study
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.
-
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
-
New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
-
Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.
-
Study Finds Evidence That Text-Based Therapy Eases Depression
A large-scale randomized trial of texting therapy concluded that its outcomes were as good as video sessions in treating depression.
-
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.